CryoLife Inc. (CRY) Jumps 6.4% on February 16

Equities Staff |

CryoLife Inc. (CRY) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 6.4% to $9.64, representing a gain of $0.58 per share. Some 118,094 shares traded hands on 927 trades, compared with an average daily volume of 68,209 shares out of a total float of 28.45 million. The stock opened at $9.21 and traded with an intraday range of $9.97 to $9.10.

After today's gains, CryoLife Inc. reached a market cap of $274.3 million. CryoLife Inc. has had a trading range between $11.75 and $8.94 over the last year, and it had a 50-day SMA of $10.01 and a 200-day SMA of $10.37.

The stock has a P/E Ratio of 90.6.

Cryolife Inc is engaged in medical device manufacturing & distribution and in the processing & distribution of implantable human tissues for use in cardiac and vascular surgeries. The Company has two segments: Medical Devices and Preservation Services.

CryoLife Inc. is based out of Kennesaw, GA and has some 535 employees. Its CEO is James Patrick Mackin.

For a complete fundamental analysis analysis of CryoLife Inc., check out’s Stock Valuation Analysis report for CRY. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

AfterMaster Inc

Studio One Media Inc is a diversified media and technology company. It is engaged in the development and commercialization of proprietary, edge audio and video technologies for professional and consumer…

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…